Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Breakthrough Allows Patients to Control Ventilator

By HospiMedica staff writers
Posted on 05 Oct 2006
A breakthrough in ventilation therapy enables patients to control the ventilator with the respiratory center in their brain.

Called NAVA (neurally adjusted ventilatory assist), the new approach to mechanical ventilation is based on the patient's neural respiratory output. More...
Signals from the respiratory control center in the brain are transmitted through the phrenic nerve to the diaphragm, where a catheter captures the electrical activity (Edi) and feeds it to the ventilator. NAVA responds by providing the requested level of ventilatory support to the patient. As the ventilator and diaphragm work with the same signal, the coupling between the two is virtually instantaneous. In contrast, conventional mechanical ventilators sense patient effort either by a drop in airway pressure or a reversal in flow.

Benefits of NAVA include improved synchrony between the patient and the ventilator, lung protection through avoidance of over- or under-assistance of the patient, and enhanced patient comfort, since the improved synchrony helps minimize patient discomfort and agitation while at the same time promoting spontaneous breathing.

The Edi signal can be used as a unique monitoring tool providing information on respiratory drive, volume requirements, and effects of ventilatory settings. It can also be used to gain an indication for sedation or weaning and to support the decisions of medical staff concerning unloading or extubation.

"NAVA is a completely new mode of mechanical ventilation where the ventilator is controlled by the patient's respiratory center on a breath-by-breath basis,” said Dr. Christer Sinderby, Ph.D., a researcher in the department of Critical Care at St. Michael's Hospital (Toronto, Canada). "In addition to being a distinct mode of ventilation, NAVA also enables a complete evaluation of the neural respiratory control thanks to the electrical activity of the diaphragm.”

The NAVA function is available on the Servo-i ventilator of Maquet Critical Care (Solna, Sweden). The only equipment required in addition to the Servo-i ventilator is NAVA software, an Edi module, and an Edi catheter. Maquet notes that current Servo-i users can upgrade an existing unit with the NAVA function. The new NAVA function was introduced by Maquet at the annual meeting of the European Society of Intensive Care Medicine (ESICM) in Barcelona (Spain) in September 2006.


Related Links:
Maquet Critical Care

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.